# Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial

> **NCT00863551** · PHASE4 · COMPLETED · sponsor: **Allergan** · enrollment: 12 (actual)

## Conditions studied

- Elderly
- Pharmacokinetics
- Overactive Bladder

## Interventions

- **DRUG:** Trospium Chloride

## Key facts

- **NCT ID:** NCT00863551
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00863551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00863551, "Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00863551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*